![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pharmaceutics, University of Washington, Seattle, Washington
Many endogenous compounds and xenobiotics are organic cations that rely on polyspecific organic cation transporters (OCTs) to traverse cell membranes. We recently cloned a novel human plasma membrane monoamine transporter (PMAT) that belongs to the equilibrative nucleoside transporter (ENT) family. We have reported previously that, unlike other ENTs, PMAT (also known as ENT4) is a Na+-independent and membrane potential-sensitive transporter that transports monoamine neurotransmitters and the neurotoxin 1-methyl-4-phenylpyridinium (MPP+). These compounds are the known substrates for OCTs, which raises the possibility that PMAT functions as a polyspecific transporter like the OCTs. In the present study, we analyzed the interaction of PMAT with a series of structurally diverse organic cations using MDCK cells stably expressing human PMAT. Our study showed that PMAT interacts with many organic cations that have heterogeneous chemical structures. PMAT transports classic OCT substrates, such as tetraethylammonium, guanidine, and histamine. Prototype OCT inhibitors, including cimetidine, and type II cations (e.g., quinidine, quinine, verapamil, and rhodamine123) are also PMAT inhibitors. An analysis of molecular structures and apparent binding affinities revealed that charge and hydrophobicity are the principal determinants for transporter-substrate/inhibitor interaction. A planar aromatic mass seems to be important for high affinity interaction. trans-Stimulation and efflux studies demonstrate that PMAT is able to mediate bidirectional transport. These functional properties of PMAT are strikingly similar to those of the OCTs. We therefore conclude that PMAT can function as a polyspecific organic cation transporter, which may play a role in organic cation transport in vivo.
Received for publication July 14, 2005.
Accepted for publication August 11, 2005.
Address correspondence to: Dr. Joanne Wang, Department of Pharmaceutics, University of Washington, H272J, Health Sciences Building, Seattle, WA 98195-7610. E-mail: jowang{at}u.washington.edu
This article has been cited by other articles:
|
|
 |
|
  L. Xia, M. Zhou, T. F. Kalhorn, H. T. B. Ho, and J. Wang Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1307 - F1313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Hansson, B. Bottalico, V. Noskova, and B. Casslen Monoamine transporters in human endometrium and decidua Hum. Reprod. Update, March 1, 2009; 15(2): 249 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Hoque, L. Chen, G. P. H. Leung, and C.-M. Tse A purine-selective nucleobase/nucleoside transporter in PK15NTD cells Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1988 - R1995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Linder, J. Diaz, W. Ni, T. Szasz, R. Burnett, and S. W. Watts Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1745 - H1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. J. Bone and J. R. Hammond Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3325 - H3332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhou, L. Xia, and J. Wang Metformin Transport by a Newly Cloned Proton-Stimulated Organic Cation Transporter (Plasma Membrane Monoamine Transporter) Expressed in Human Intestine Drug Metab. Dispos., October 1, 2007; 35(10): 1956 - 1962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, N. J. Cherrington, and S. H. Wright Molecular identification and functional characterization of rabbit MATE1 and MATE2-K Am J Physiol Renal Physiol, July 1, 2007; 293(1): F360 - F370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhou, L. Xia, K. Engel, and J. Wang Molecular Determinants of Substrate Selectivity of a Novel Organic Cation Transporter (PMAT) in the SLC29 Family J. Biol. Chem., February 2, 2007; 282(5): 3188 - 3195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xia, K. Engel, M. Zhou, and J. Wang Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells Am J Physiol Renal Physiol, February 1, 2007; 292(2): F682 - F690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Bubien and D. J. Benos Molecular pH Probes: Mediators of Angina and Ischemic Preconditioning? Circ. Res., September 1, 2006; 99(5): 453 - 454. [Full Text] [PDF]
|
|
|
|
|
|
K. Barnes, H. Dobrzynski, S. Foppolo, P. R. Beal, F. Ismat, E. R. Scullion, L. Sun, J. Tellez, M. W.L. Ritzel, W. C. Claycomb, et al. Distribution and Functional Characterization of Equilibrative Nucleoside Transporter-4, a Novel Cardiac Adenosine Transporter Activated at Acidic pH Circ. Res., September 1, 2006; 99(5): 510 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Noskova, B. Bottalico, H. Olsson, A. Ehinger, R. Pilka, B. Casslen, and S. R. Hansson Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2 Mol. Hum. Reprod., August 1, 2006; 12(8): 483 - 489. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
